SYRE
Spyre Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -7.1% ·
aandelenstroom -1.7% ·
netto nieuwe posities -7.7%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 99 | +22 | 55.43M | $4.93B | +25 | −3 |
| Q1 2026 | 80 | +10 | 41.69M | $2.10B | +12 | −2 |
| Q4 2025 | 69 | +2 | 41.90M | $1.37B | +2 | — |
| Q3 2025 | 13 | -1 | 23.21M | $388.94M | +1 | −2 |
| Q2 2025 | 11 | 0 | 22.40M | $335.38M | +2 | −2 |
| Q1 2025 | 8 | -2 | 6.01M | $96.96M | — | −2 |
| Q4 2024 | 10 | +1 | 7.67M | $178.64M | +2 | −1 |
| Q3 2024 | 8 | 0 | 4.78M | $140.58M | +1 | −1 |
| Q2 2024 | 8 | — | 3.96M | $93.00M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 9.06M | +0.1% | $151.85M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 9.06M | +0.1% | $151.85M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 9.06M | +0.1% | $151.85M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 3.98M | -0.6% | $66.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 3.98M | -0.6% | $66.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 3.98M | -0.6% | $66.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 3.98M | -0.6% | $66.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 3.98M | -0.6% | $66.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 3.98M | -0.6% | $66.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 3.98M | -0.6% | $66.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 3.98M | -0.6% | $66.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 3.98M | -0.6% | $66.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 3.98M | -0.6% | $66.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 3.98M | -0.6% | $66.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passief) | 3.05M | -0.5% | $51.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passief) | 3.05M | -0.5% | $51.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passief) | 3.05M | -0.5% | $51.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passief) | 3.05M | -0.5% | $51.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passief) | 3.05M | -0.5% | $51.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | State Street Global Advisors ✦ (passief) | 1.79M | +11.9% | $29.92M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Wellington Management ✦ | 1.64M | +8.4% | $27.49M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | Wellington Management ✦ | 1.64M | +8.4% | $27.49M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | Wellington Management ✦ | 1.64M | +8.4% | $27.49M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 24 | Wellington Management ✦ | 1.64M | +8.4% | $27.49M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 25 | Wellington Management ✦ | 1.64M | +8.4% | $27.49M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 26 | Geode Capital Management ✦ (passief) | 1.23M | -0.2% | $20.54M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 27 | Geode Capital Management ✦ (passief) | 1.23M | -0.2% | $20.54M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 28 | T. Rowe Price ✦ | 620.62K | -33.3% | $10.40M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 29 | T. Rowe Price ✦ | 620.62K | -33.3% | $10.40M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 551.97K | — | $9.25M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 551.97K | — | $9.25M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 551.97K | — | $9.25M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 551.97K | — | $9.25M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 551.97K | — | $9.25M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 551.97K | — | $9.25M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 551.97K | — | $9.25M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 551.97K | — | $9.25M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Millennium Management ✦ | 408.20K | Nieuw | $6.84M | 0.0% | New | 1 | SEC ↗ |
| 39 | Morgan Stanley ✦ | 334.72K | — | $5.61M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Morgan Stanley ✦ | 334.72K | — | $5.61M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Morgan Stanley ✦ | 334.72K | — | $5.61M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Morgan Stanley ✦ | 334.72K | — | $5.61M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Morgan Stanley ✦ | 334.72K | — | $5.61M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Morgan Stanley ✦ | 334.72K | — | $5.61M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Goldman Sachs Group ✦ | 329.53K | — | $5.52M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Goldman Sachs Group ✦ | 329.53K | — | $5.52M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Capital World Investors ✦ | 200.17K | -42.9% | $3.35M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 48 | AQR Capital Management ✦ | 17.05K | -5.2% | $285,709 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 49 | AQR Capital Management ✦ | 17.05K | -5.2% | $285,709 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 50 | AQR Capital Management ✦ | 17.05K | -5.2% | $285,709 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 51 | AQR Capital Management ✦ | 17.05K | -5.2% | $285,709 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Millennium Management | $6.84M | 0.0% |
Verlaten
| Adage Capital Partners | $9.13M | was 0.0% |
| Renaissance Technologies | $463,112 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 197 houders, 82.12M aandelen, $4.06B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Director · 5.00K aand · $522,350
Director · 8.00K aand · $835,040
Director · 10.00K aand · $1.05M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie
9.2% van klasse · Originele SEC-indiening bekijken ↗